Invesco’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-58,038
| Closed | -$26.2K | – | 3816 |
|
|
2025
Q1 | $26.2K | Sell |
58,038
-3,747
| -6% | -$2.2K | ﹤0.01% | 3734 |
|
|
2024
Q4 | $31K | Buy |
61,785
+1,272
| +2% | +$934 | ﹤0.01% | 3726 |
|
|
2024
Q3 | $54.8K | Buy |
60,513
+3,749
| +7% | +$3.48K | ﹤0.01% | 3674 |
|
|
2024
Q2 | $56.6K | Buy |
56,764
+15
| +0% | +$17 | ﹤0.01% | 3811 |
|
|
2024
Q1 | $84K | Sell |
56,749
-130
| -0.2% | -$147 | ﹤0.01% | 3761 |
|
|
2023
Q4 | $62K | Sell |
56,879
-9,013
| -14% | -$9.87K | ﹤0.01% | 3735 |
|
|
2023
Q3 | $77.8K | Hold |
65,892
| – | – | ﹤0.01% | 3756 |
|
|
2023
Q2 | $92.9K | Buy |
+65,892
| New | +$91.1K | ﹤0.01% | 3741 |
|
|
2022
Q2 | – | Sell |
-34,518
| Closed | -$53K | – | 4096 |
|
|
2022
Q1 | $53K | Sell |
34,518
-7,765
| -18% | -$12K | ﹤0.01% | 3927 |
|
|
2021
Q4 | $103K | Sell |
42,283
-13,360
| -24% | -$31.3K | ﹤0.01% | 3898 |
|
|
2021
Q3 | $140K | Buy |
55,643
+11,196
| +25% | +$28.7K | ﹤0.01% | 3879 |
|
|
2021
Q2 | $126K | Buy |
+44,447
| New | +$115K | ﹤0.01% | 3862 |
|
|
2019
Q1 | – | Sell |
-33,796
| Closed | -$31K | – | 3764 |
|
|
2018
Q4 | $31K | Sell |
33,796
-4,491
| -12% | -$6.88K | ﹤0.01% | 3735 |
|
|
2018
Q3 | $79K | Sell |
38,287
-6,268
| -14% | -$13.2K | ﹤0.01% | 3799 |
|
|
2018
Q2 | $80K | Sell |
44,555
-77,279
| -63% | -$156K | ﹤0.01% | 3787 |
|
|
2018
Q1 | $287K | Sell |
121,834
-4,830
| -4% | -$11.3K | ﹤0.01% | 3512 |
|
|
2017
Q4 | $238K | Sell |
126,664
-1,894
| -1% | -$4.14K | ﹤0.01% | 3502 |
|
|
2017
Q3 | $319K | Sell |
128,558
-767
| -0.6% | -$1.9K | ﹤0.01% | 3436 |
|
|
2017
Q2 | $356K | Buy |
+129,325
| New | +$361K | ﹤0.01% | 3430 |
|
|
2015
Q3 | – | Sell |
-1,643
| Closed | -$5K | – | 3899 |
|
|
2015
Q2 | $5K | Buy |
+1,643
| New | +$6.37K | ﹤0.01% | 4204 |
|
Other funds holding LCTX
BC
DC
RA
